|
Real-time Estimate
Cboe BZX
22:19:22 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.6040 USD | -31.35% |
|
+14.61% | -91.94% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
CBOE
| KPTI | Real-time | |
Tradegate
| 25K0 | Real-time | |
Deutsche Boerse AG
| 25K0 | Delayed | |
Börse Stuttgart
| 25K0 | Delayed | |
Boerse Muenchen
| 25K0 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.88 | 1.88 | 1.88 |
| Spread/Res. | -68.45% | -68.45% | -68.45% |
| Spread/Supp. | +88.29% | +88.29% | +52.04% |
| Support | 0.315 | 0.315 | 0.3901 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions

















